ACUTE EFFECTS OF MK421, A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, IN MAN

被引:5
作者
KASAI, Y [1 ]
ABE, K [1 ]
YASUJIMA, M [1 ]
TAJIMA, J [1 ]
SEINO, M [1 ]
CHIBA, S [1 ]
SATO, K [1 ]
GOTO, T [1 ]
OMATA, K [1 ]
TANNO, M [1 ]
YOSHINAGA, K [1 ]
机构
[1] TOHOKU UNIV, SCH MED,DEPT INTERNAL MED 2, SENDAI, MIYAGI 980, JAPAN
关键词
D O I
10.1620/tjem.141.417
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:417 / 422
页数:6
相关论文
共 50 条
  • [21] CAPTOPRIL - AN ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR ACTIVE IN MAN
    BRUNNER, HR
    GAVRAS, H
    WAEBER, B
    TURINI, GA
    WAUTERS, JP
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1980, : 188 - 212
  • [22] CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK421) IN TREATMENT OF HYPERTENSION WITH RENAL-ARTERY STENOSIS
    HODSMAN, GP
    BROWN, JJ
    DAVIES, DL
    FRASER, R
    LEVER, AF
    MORTON, JJ
    MURRAY, GD
    ROBERTSON, JIS
    BMJ-BRITISH MEDICAL JOURNAL, 1982, 285 (6356): : 1697 - 1699
  • [23] EFFECTS ON AUTONOMIC FUNCTION OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, RAMIPRIL
    SUGIMOTO, K
    KUMAGAI, Y
    TATEISHI, T
    SEGUCHI, H
    EBIHARA, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S40 - S45
  • [24] ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY MK421 - A POTENT LONG-ACTING ORAL-AGENT
    JACKSON, B
    JOHNSTON, CI
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (04): : 362 - 362
  • [25] LISINOPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    CHASE, SL
    SUTTON, JD
    PHARMACOTHERAPY, 1989, 9 (03): : 120 - 130
  • [26] LISINOPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    ARMAYOR, GM
    LOPEZ, LM
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (05): : 365 - 372
  • [27] ACUTE EFFECTS OF THE NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CILAZAPRIL - A PILOT-STUDY
    MULINARI, RA
    GOUNI, I
    GAVRAS, I
    GAVRAS, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (07) : 660 - 663
  • [28] ENALAPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    WEINTRAUB, M
    EVANS, P
    HOSPITAL FORMULARY, 1985, 20 (07): : 796 - &
  • [29] INFLUENCE OF THE CONVERTING ENZYME-INHIBITOR (CEI)-MK421 AND ITS LYSINE ANALOGUE-MK521 ON BLOOD-PRESSURE (BP), PRESSOR HORMONES AND AUTONOMIC REFLEXES
    MILLAR, JA
    DERKX, FHM
    REID, JL
    CLINICAL RESEARCH, 1982, 30 (01): : A26 - A26
  • [30] ACUTE, SUBCHRONIC AND CHRONIC TOXICITY OF THE NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR RAMIPRIL
    DONAUBAUER, HH
    MAYER, D
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (01): : 14 - 20